Takeaways: The pCPA Letter of Intent for Anzupgo (delgocitinib cream) moves Canada closer to public reimbursement for the first topical therapy specifically indicated for moderate to severe chro...
Takeaways: Siliq’s listing under Alberta’s public drug plan expands brodalumab’s public coverage across Canada, leaving only British Columbia without provincial reimbursement and improving...
Takeaways: CDA-AMC’s conditional reimbursement recommendation for Yorvipath moves the therapy closer to public funding in Canada for adults with chronic hypoparathyroidism who are not ...
Takeaways: PixCell Medical’s Health Canada license and distribution partnership with Inter Medico give HemoScreen a direct route into Canada’s growing point-of-care diagnostics ma...
Takeaways: The positive reimbursement recommendation from Canada’s drug agency moves Leqembi closer to public funding for early Alzheimer’s disease, which can significantly expand the ...
Takeaways: Health Canada’s approval of Fujirebio’s Lumipulse G NfL Blood and pTau217 Plasma assays brings two high‑demand, blood‑based neurology tests into the Canadian marke...
Felix Health launches sleep apnea care in Canada through collaboration with MedSleep Felix Health announced the launch of sleep apnea care across Ontario, British Columbia, and Alberta through a new c...
Takeaways: The Canadian government’s funding supports Kardium’s plan to expand manufacturing and cleanroom capacity in Vancouver, enabling the company to scale production of its Globe Pulsed Fie...
Takeaways: The launch expands Olympus’ footprint in the growing open-surgery vessel-sealing segment and reinforces its platform strategy, making it easier for hospitals to standardiz...
Takeaways: Felix’s sleep apnea program, built with MedSleep, creates a virtual front door for one of Canada’s most under‑diagnosed chronic conditions (≈1 in 4 adults at high risk, only ~3%...
